Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

CytoSorbents Corp (CTSO) USD0.001

Sell:$8.33 Buy:$8.37 Change: $0.17 (2.08%)
NASDAQ:0.92%
Market closed |  Prices as at close on 27 November 2020 | Switch to live prices |
Sell:$8.33
Buy:$8.37
Change: $0.17 (2.08%)
Market closed |  Prices as at close on 27 November 2020 | Switch to live prices |
Sell:$8.33
Buy:$8.37
Change: $0.17 (2.08%)
Market closed |  Prices as at close on 27 November 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads that remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. The Company's CytoSorb is an extracorporeal cytokine filter and is designed to reduce the cytokine storm that causes inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury and pancreatitis. In addition, CytoSorb is used in other inflammatory conditions, such as cardiac surgery, autoimmune disease flares, cancer, cytokine release syndrome in cancer immunotherapy and cancer cachexia.

Contact details

Address:
7 Deerpark Dr Ste K
MONMOUTH JUNCTION
08852-1977
United States
Telephone:
+ ()
Website:
cytosorbents.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CTSO
ISIN:
US23283X2062
Market cap:
$353.61 million
Shares in issue:
43.18 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Phillip Chan
    President, Chief Executive Officer, Director
  • Kathleen Bloch
    Chief Financial Officer
  • Vincent Capponi
    Chief Operating Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.